Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos

El uso de métodos anticonceptivos ha presentado problemas de adherencia y aceptabilidad en Colombia y el mundo. Distintos estudios de la OMS indican que las mujeres aún cuando desean evitar el embarazo dejan de usar estos métodos debido a los efectos secundarios que presentan. La industria fármacéut...

Full description

Autores:
Reina López, Laura Camila
Rodríguez Tavera, Ricardo Andrés
Tipo de recurso:
https://purl.org/coar/resource_type/c_7a1f
Fecha de publicación:
2024
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
spa
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/14370
Acceso en línea:
https://hdl.handle.net/20.500.12495/14370
Palabra clave:
Parches transdérmicos de microagujas
Liberación controlada
Microagujas biodegradables
Levonorgestrel
Aceptabilidad
Adherencia
615.19
Transdermal microneedle patches
Controlled release
Biodegradable microneedles
Levonorgestrel
Acceptability
Adherence
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 International
id UNBOSQUE2_a2ed1cd856af053b916de5b06bccaf8b
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/14370
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.none.fl_str_mv Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
dc.title.translated.none.fl_str_mv Literature review: Transdermal microneedle patches transdermal microneedle patches for contraceptive drug delivery
title Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
spellingShingle Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
Parches transdérmicos de microagujas
Liberación controlada
Microagujas biodegradables
Levonorgestrel
Aceptabilidad
Adherencia
615.19
Transdermal microneedle patches
Controlled release
Biodegradable microneedles
Levonorgestrel
Acceptability
Adherence
title_short Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
title_full Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
title_fullStr Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
title_full_unstemmed Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
title_sort Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
dc.creator.fl_str_mv Reina López, Laura Camila
Rodríguez Tavera, Ricardo Andrés
dc.contributor.advisor.none.fl_str_mv Velandia Paris, María Angélica
dc.contributor.author.none.fl_str_mv Reina López, Laura Camila
Rodríguez Tavera, Ricardo Andrés
dc.subject.none.fl_str_mv Parches transdérmicos de microagujas
Liberación controlada
Microagujas biodegradables
Levonorgestrel
Aceptabilidad
Adherencia
topic Parches transdérmicos de microagujas
Liberación controlada
Microagujas biodegradables
Levonorgestrel
Aceptabilidad
Adherencia
615.19
Transdermal microneedle patches
Controlled release
Biodegradable microneedles
Levonorgestrel
Acceptability
Adherence
dc.subject.ddc.none.fl_str_mv 615.19
dc.subject.keywords.none.fl_str_mv Transdermal microneedle patches
Controlled release
Biodegradable microneedles
Levonorgestrel
Acceptability
Adherence
description El uso de métodos anticonceptivos ha presentado problemas de adherencia y aceptabilidad en Colombia y el mundo. Distintos estudios de la OMS indican que las mujeres aún cuando desean evitar el embarazo dejan de usar estos métodos debido a los efectos secundarios que presentan. La industria fármacéutica ha explorado diversos métodos anticonceptivos, en donde se han incluido los parches transdérmicos de microagujas como una alternativa con menos efectos secundarios y mayor adherencia al tratamiento. Se realizó una revisión bibliográfica utilizando la metodología PRISMA, donde se emplearon criterios de inclusión y exclusión, allí se analizaron 50 artículos con el fin de dar cumplimiento a los objetivos planteados. Se determinó que los parches transdérmicos de microagujas ofrecen ventajas significativas como una liberación controlada de fármacos. Los diferentes tipos de microagujas (sólidas, recubiertas, biodegradables, huecas y de hidrogel), demostraron diferencias en eficacia y caracteristicas de liberación. Las microagujas biodegradables permiten una liberación controlada de Levonorgestrel de hasta 45 días sin dejar ningún residuo biopeligroso, lo que convierte a los parches transdérmicos de microagujas en una opción innovadora y viable para la administración de Levonorgestrel debido a que facilita la entrega, siendo más eficiente y controlada, permitiendo mayor adherencia y aceptabilidad por los pacientes.
publishDate 2024
dc.date.issued.none.fl_str_mv 2024-10
dc.date.accessioned.none.fl_str_mv 2025-05-16T16:33:48Z
dc.date.available.none.fl_str_mv 2025-05-16T16:33:48Z
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.local.none.fl_str_mv Tesis/Trabajo de grado - Monografía - Pregrado
dc.type.coar.none.fl_str_mv https://purl.org/coar/resource_type/c_7a1f
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.coarversion.none.fl_str_mv https://purl.org/coar/version/c_ab4af688f83e57aa
format https://purl.org/coar/resource_type/c_7a1f
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12495/14370
dc.identifier.instname.spa.fl_str_mv Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv repourl:https://repositorio.unbosque.edu.co
url https://hdl.handle.net/20.500.12495/14370
identifier_str_mv Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
repourl:https://repositorio.unbosque.edu.co
dc.language.iso.fl_str_mv spa
language spa
dc.relation.references.none.fl_str_mv 1. Bitzer, J. La Realidad de Los Métodos Anticonceptivos. SciELO 2018, 23.
2. Organización Mundial de la Salud Un Nuevo Estudio de La OMS Relaciona Las Altas Tasas de Embarazos No Planificados Con Las Deficiencias de Los Servicios de Planificación Familiar Available online: https://www.who.int/es/news/item/25-10-2019-high-rates-of-unintended-pregnancies-linked-to-gaps-in-family-planning-services-new-who-study.
3. Gordon, L.P. El Método Ogino (o de Abstinencia Periódica Basada En El Ciclo Menstrual) Available online: https://kidshealth.org/es/teens/contraception-rhythm.html#:~:text=El%20m%C3%A9todo%20Ogino%20es%20una,ciclo%20mensual%20de%20una%20mujer.
4. Cuervo-Vergara, S.A.; Garrido-Gutiérrez, J.D.; Vélez-Álvarez, G.A.; Zuleta-Tobón, J.J. Asociación Entre Conocimientos de Anticoncepción y Embarazo No Planeado. Estudio de Corte Transversal. Rev Colomb Obstet Ginecol 2015, 66, 160, doi:10.18597/rcog.21.
5. Organización Mundial de la Salud Organización Mundial de La Salud Departamento de Salud Reproductiva e Investigaciones Conexas.
6. MinSalud; Profamilia Encuesta Nacional de Demografía y Salud; 2015;
7. MinSalud; Profamilia Conocimiento y Uso de Los Métodos Anticonceptivos Entre Los Colombianos Available online: https://www.minsalud.gov.co/Documents/General/20161212_B_ENDS%202015_Metodos_anticonceptivos.pdf.
8. Park, P. Park’s Textbook of Preventive and Social Medicine; 24th ed.; Banarsidas Bhanot Publishers, 2017;
9. National Institutes of Health ¿Cuáles Son Los Diferentes Tipos de Anticonceptivos? Available online: https://espanol.nichd.nih.gov/salud/temas/contraception/informacion/tipos.
10. AEMPS Parches Transdérmicos
11. Goldsmith, A.; Edelman, D.A. Tecnología Anticonceptiva: Presente y Futuro. Rev Colomb Obstet Ginecol 2021, 30, 93–101, doi:10.18597/rcog.2253.
12. Chen, X.; Z.Y.-P.X.J.S.X.-L.L.Y.G.L.W.Z.-H. [Preparation of Triptolide-Loaded Dissolving Microneedles and Its Transdermal Penetration]. Pubmed 2021, 46, 5278–5283, doi:10.19540/j.cnki.cjcmm.20210330.303.
13. McCrudden, M.T.C.; McAlister, E.; Courtenay, A.J.; González‐Vázquez, P.; Raj Singh, T.R.; Donnelly, R.F. Microneedle Applications in Improving Skin Appearance. Exp Dermatol 2015, 24, 561–566, doi:10.1111/exd.12723.
14. Gómez Sánchez, P.I. ANTICONCEPCIÓN: PASADO, PRESENTE Y FUTURO; 1st ed.; Editorial Universidad Nacional de Colombia, 2010;
15. Bitzer, J.; Gemzell-Danielsson, K.; Roumen, F.; Marintcheva-Petrova, M.; van Bakel, B.; Oddens, B.J. The CHOICE Study: Effect of Counselling on the Selection of Combined Hormonal Contraceptive Methods in 11 Countries. The European Journal of Contraception & Reproductive Health Care 2012, 17, 65–78, doi:10.3109/13625187.2011.637586.
16. Karve, T.; Dandekar, A.; Agrahari, V.; Melissa Peet, M.; Banga, A.K.; Doncel, G.F. Long-Acting Transdermal Drug Delivery Formulations: Current Developments and Innovative Pharmaceutical Approaches. Adv Drug Deliv Rev 2024, 210, doi:10.1016/j.addr.2024.115326.
17. Gupta, D.R.; Prabhakar, B.; Wairkar, S. Non-Oral Routes, Novel Formulations and Devices of Contraceptives: An Update. Journal of Controlled Release 2022, 345, 798–810, doi:10.1016/j.jconrel.2022.03.057.
18. Rojas Mena, A.A. AVANCES EN TECNOLOGÍA: PARCHES DE MICROAGUJAS. Trabajo Fin de Grado, UNIVERSIDAD COMPLUTENSE, 2017.
19. María Pilar Nakhle Eid Avances En Los Sistemas Transdermicos Para La Administracion de Farmacos (4), Universidad de la Laguna, 2022.
20. Baryakova, T.H.; Pogostin, B.H.; Langer, R.; McHugh, K.J. Overcoming Barriers to Patient Adherence: The Case for Developing Innovative Drug Delivery Systems. Nat Rev Drug Discov 2023, 22, 387–409, doi:10.1038/s41573-023-00670-0.
21. Lee, D.H.; Lim, S.; Kwak, S.S.; Kim, J. Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications. Adv Healthc Mater 2024, 13, doi:10.1002/adhm.202302375.
22. Berdai Jiménez, S. El Administración Transdérmica de Fármacos En Microagujas. Trabajo fin de Grado, UNIVERSIDAD COMPLUTENSE, 2020.
23. Le, Z.; Yu, J.; Quek, Y.J.; Bai, B.; Li, X.; Shou, Y.; Myint, B.; Xu, C.; Tay, A. Design Principles of Microneedles for Drug Delivery and Sampling Applications. Materials Today 2023, 63, 137–169, doi:10.1016/j.mattod.2022.10.025.
24. Jung, J.H.; Jin, S.G. Microneedle for Transdermal Drug Delivery: Current Trends and Fabrication. J Pharm Investig 2021, 51, 503–517, doi:10.1007/s40005-021-00512-4.
25. Wong, W.F.; Ang, K.P.; Sethi, G.; Looi, C.Y. Recent Advancement of Medical Patch for Transdermal Drug Delivery. Medicina (Lithuania) 2023, 59, doi:10.3390/medicina59040778.
26. Yao, G.; Quan, G.; Lin, S.; Peng, T.; Wang, Q.; Ran, H.; Chen, H.; Zhang, Q.; Wang, L.; Pan, X.; et al. Novel Dissolving Microneedles for Enhanced Transdermal Delivery of Levonorgestrel: In Vitro and in Vivo Characterization. Int J Pharm 2017, 534, 378–386, doi:10.1016/j.ijpharm.2017.10.035.
27. Altuntaş, E.; Tekko, I.A.; Vora, L.K.; Kumar, N.; Brodsky, R.; Chevallier, O.; McAlister, E.; Kurnia Anjani, Q.; McCarthy, H.O.; Donnelly, R.F. Nestorone Nanosuspension-Loaded Dissolving Microneedles Array Patch: A Promising Novel Approach for “on-Demand” Hormonal Female-Controlled Peritcoital Contraception. Int J Pharm 2022, 614, doi:10.1016/j.ijpharm.2021.121422.
28. Jiang, X.; Zeng, Y.; Zhang, W.; Wang, C.; Li, W. Advances in Microneedle Patches for Long-Acting Contraception. Acta Materia Medica 2023, 2, doi:10.15212/AMM-2022-0042.
29. Li, W.; Terry, R.N.; Tang, J.; Feng, M.R.; Schwendeman, S.P.; Prausnitz, M.R. Rapidly Separable Microneedle Patch for the Sustained Release of a Contraceptive. Nat Biomed Eng 2019, 3, 220–229, doi:10.1038/s41551-018-0337-4.
30. Abdelkader, H.; Fathalla, Z.; Seyfoddin, A.; Farahani, M.; Thrimawithana, T.; Allahham, A.; Alani, A.W.G.; Al-Kinani, A.A.; Alany, R.G. Polymeric Long-Acting Drug Delivery Systems (LADDS) for Treatment of Chronic Diseases: Inserts, Patches, Wafers, and Implants. Adv Drug Deliv Rev 2021, 177, doi:10.1016/j.addr.2021.113957.
31. Zhang, W.; Zhang, W.; Li, C.; Zhang, J.; Qin, L.; Lai, Y. Recent Advances of Microneedles and Their Application in Disease Treatment. Int J Mol Sci 2022, 23, doi:10.3390/ijms23052401.
32. Yadav, P.R.; Munni, M.N.; Campbell, L.; Mostofa, G.; Dobson, L.; Shittu, M.; Pattanayek, S.K.; Uddin, M.J.; Bhusan Das, D. Translation of Polymeric Microneedles for Treatment of Human Diseases: Recent Trends, Progress, and Challenges. Pharmaceutics 2021, 13, doi:10.3390/pharmaceutics13081132.
33. Avcil, M.; Çelik, A. Microneedles in Drug Delivery: Progress and Challenges. Micromachines (Basel) 2021, 12, doi:10.3390/mi12111321.
34. Priya, B.; Manoj, K.; Navneet, K. A Review of Recent Advancement of Transdermal Drug Delivery Systems. International Journal of Research Development and Technology 2023, 1.
35. Sheth, N.S.; Mistry, R.B. Formulation and Evaluation of Transdermal Patches and to Study Permeation Enhancement Effect of Eugenol. J Appl Pharm Sci 2011, 01, 96–101.
36. Kim, S.; Kim, J.H.; Jeon, O.; Kwon, I.C.; Park, K. Engineered Polymers for Advanced Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics 2009, 71, 420–430, doi:10.1016/j.ejpb.2008.09.021.
37. Vora, L.K.; Sabri, A.H.; Naser, Y.; Himawan, A.; Hutton, A.R.J.; Anjani, Q.K.; Volpe-Zanutto, F.; Mishra, D.; Li, M.; Rodgers, A.M.; et al. Long-Acting Microneedle Formulations. Adv Drug Deliv Rev 2023, 201, doi:10.1016/j.addr.2023.115055.
38. Parhi, R. Recent Advances in Microneedle Designs and Their Applications in Drug and Cosmeceutical Delivery. J Drug Deliv Sci Technol 2022, 75, doi:10.1016/j.jddst.2022.103639.
39. Filho, D.; Guerrero, M.; Pariguana, M.; Marican, A.; Durán-Lara, E.F. Hydrogel-Based Microneedle as a Drug Delivery System. Pharmaceutics 2023, 15, doi:10.3390/pharmaceutics15102444.
40. Hou, X.; Li, J.; Hong, Y.; Ruan, H.; Long, M.; Feng, N.; Zhang, Y. Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery. Biomedicines 2023, 11, doi:10.3390/biomedicines11082119.
41. Luo, X.; Yang, L.; Cui, Y. Microneedles: Materials, Fabrication, and Biomedical Applications. Biomed Microdevices 2023, 25, doi:10.1007/s10544-023-00658-y.
42. Parhi, R.; Divya Supriya, N. Review of Microneedle Based Transdermal Drug Delivery Systems. International Journal of Pharmaceutical Sciences and Nanotechnology 2019, 12, doi:10.37285/ijpsn.2019.12.3.1.
43. Halder, J.; Gupta, S.; Kumari, R.; Gupta, G. Das; Rai, V.K. Microneedle Array: Applications, Recent Advances, and Clinical Pertinence in Transdermal Drug Delivery. J Pharm Innov 2021, 16, 558–565, doi:10.1007/s12247-020-09460-2.
44. Rathor, S.; Ram, A.; Ghasidas Vishwavidyalaya, G. ADVANCEMENT IN TRANSDERMAL DRUG DELIVERY SYSTEM : MICRONEEDLES. Asian Journal of Pharmaceutical Research and Development 2017, 5, 1–07.
45. Oliveira, C.; Teixeira, J.A.; Oliveira, N.; Ferreira, S.; Botelho, C.M. Microneedles’ Device: Design, Fabrication, and Applications. Macromol 2024, 4, 320–355, doi:10.3390/macromol4020019.
46. Vora, L.K.; Moffatt, K.; Tekko, I.A.; Paredes, A.J.; Volpe-Zanutto, F.; Mishra, D.; Peng, K.; Raj Singh Thakur, R.; Donnelly, R.F. Microneedle Array Systems for Long-Acting Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics 2021, 159, 44–76, doi:10.1016/j.ejpb.2020.12.006.
47. Singh, P.; Carrier, A.; Chen, Y.; Lin, S.; Wang, J.; Cui, S.; Zhang, X. Polymeric Microneedles for Controlled Transdermal Drug Delivery. Journal of Controlled Release 2019, 315, 97–113, doi:10.1016/j.jconrel.2019.10.022.
48. Wang, S.; Zhao, M.; Yan, Y.; Li, P.; Huang, W. Flexible Monitoring, Diagnosis, and Therapy by Microneedles with Versatile Materials and Devices toward Multifunction Scope. Research 2023, 6, 01–28, doi:10.34133/research.0128.
49. Loh, J.M.; Lim, Y.J.L.; Tay, J.T.; Cheng, H.M.; Tey, H.L.; Liang, K. Design and Fabrication of Customizable Microneedles Enabled by 3D Printing for Biomedical Applications. Bioact Mater 2024, 32, 222–241, doi:10.1016/j.bioactmat.2023.09.022.
50. Serrano Castañeda, P. Desarrollo de Una Nueva Forma Farmacéutica a Base de Microagujas Poliméricas Biodegradables Acopladas a Un Parche Transdérmico Para La Liberación de Fármacos. Tesis, UNIVERSIDAD AUTÓNOMA METROPOLITANA, 2019.
51. Magill, E.; Demartis, S.; Gavini, E.; Permana, A.D.; Thakur, R.R.S.; Adrianto, M.F.; Waite, D.; Glover, K.; Picco, C.J.; Korelidou, A.; et al. Solid Implantable Devices for Sustained Drug Delivery. Adv Drug Deliv Rev 2023, 199, doi:10.1016/j.addr.2023.114950.
52. Conrad, R. ¿Qué Es Moldeo Por Inyección? Available online: https://www.elastomer.kuraray.com/es/blog/injection-molding/ (accessed on 21 September 2024).
53. Xu, J.; Xu, D.; Xuan, X.; He, H. Advances of Microneedles in Biomedical Applications. Molecules 2021, 26, doi:10.3390/molecules26195912.
54. Ramadon, D.; McCrudden, M.T.C.; Courtenay, A.J.; Donnelly, R.F. Enhancement Strategies for Transdermal Drug Delivery Systems: Current Trends and Applications. Drug Deliv Transl Res 2022, 12, 758–791, doi:10.1007/s13346-021-00909-6.
55. Sabri, A.H.; Kim, Y.; Marlow, M.; Scurr, D.J.; Segal, J.; Banga, A.K.; Kagan, L.; Lee, J.B. Intradermal and Transdermal Drug Delivery Using Microneedles – Fabrication, Performance Evaluation and Application to Lymphatic Delivery. Adv Drug Deliv Rev 2020, 153, 195–215, doi:10.1016/j.addr.2019.10.004.
56. Morales Florido, M.I.; Miranda Calderón, J.E.; Gómez Sámano, M.A.; Escobar Chávez, J.J. Microneedles as an Alternative Strategy for Drug Delivery. J Pharm Pharm Sci 2022, 25, 93–109.
57. Ebrahiminejad, V.; Rad, Z.F.; Prewett, P.D.; Davies, G.J. Fabrication and Testing of Polymer Microneedles for Transdermal Drug Delivery. Beilstein Journal of Nanotechnologyp0o 2022, 13, 629–640, doi:10.3762/bjnano.13.55.
58. Li, W.; Tang, J.; Terry, R.N.; Li, S.; Brunie, A.; Callahan, R.L.; Noel, R.K.; Rodríguez, C.A.; Schwendeman, S.P.; Prausnitz, M.R. Long-Acting Reversible Contraception by Effervescent Microneedle Patch. Sci Adv 2019, 5.
59. Li, W.; Chen, J.Y.; Terry, R.N.; Tang, J.; Romanyuk, A.; Schwendeman, S.P.; Prausnitz, M.R. Core-Shell Microneedle Patch for Six-Month Controlled-Release Contraceptive Delivery. Journal of Controlled Release 2022, 347, 489–499, doi:10.1016/j.jconrel.2022.04.051.
60. Paredes, A.J.; Ramöller, I.K.; McKenna, P.E.; Abbate, M.T.A.; Volpe-Zanutto, F.; Vora, L.K.; Kilbourne-Brook, M.; Jarrahian, C.; Moffatt, K.; Zhang, C.; et al. Microarray Patches: Breaking down the Barriers to Contraceptive Care and HIV Prevention for Women across the Globe. Adv Drug Deliv Rev 2021, 173, 331–348, doi:10.1016/j.addr.2021.04.002.
61. Xu, C.; Wu, Y.; Zhao, L.; Zhou, W.; Li, Y.; Yi, X.; Wang, Y.; Zhang, Q.; Hu, H.; Wang, Z. Transdermal Hormone Delivery: Strategies, Application and Modality Selection. J Drug Deliv Sci Technol 2023, 86, doi:10.1016/j.jddst.2023.104730.
62. Yavuz, B.; Chambre, L.; Harrington, K.; Kluge, J.; Valenti, L.; Kaplan, D.L. Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel. ACS Appl Bio Mater 2020, 3, 5375–5382, doi:10.1021/acsabm.0c00671.
63. Sivasankaran, S.; Jonnalagadda, S. Advances in Controlled Release Hormonal Technologies for Contraception: A Review of Existing Devices, Underlying Mechanisms, and Future Directions. Journal of Controlled Release 2021, 330, 797–811, doi:10.1016/j.jconrel.2020.12.044.
64. VADEMECUM ORTHO EVRA Transdermal Patch 150 Μg/24 H+20 Μg/24 h Available online: https://www.vademecum.es/estados-unidos/medicamento/28003194/ortho-evra-transdermal-patch-150-g-24-h-20-g-24-h (accessed on 18 September 2024).
65. Li, W.; Li, S.; Fan, X.; Prausnitz, M.R. Microneedle Patch Designs to Increase Dose Administered to Human Subjects. Journal of Controlled Release 2021, 339, 350–360, doi:10.1016/j.jconrel.2021.09.036.
dc.rights.en.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.none.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv https://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Acceso abierto
https://purl.org/coar/access_right/c_abf2
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.program.spa.fl_str_mv Química Farmacéutica
dc.publisher.grantor.spa.fl_str_mv Universidad El Bosque
dc.publisher.faculty.spa.fl_str_mv Facultad de Ciencias
institution Universidad El Bosque
bitstream.url.fl_str_mv https://repositorio.unbosque.edu.co/bitstreams/5994f216-e4bc-428f-bea3-f47c42129827/download
https://repositorio.unbosque.edu.co/bitstreams/3488d174-4a7d-428e-94c3-fe89932ca878/download
https://repositorio.unbosque.edu.co/bitstreams/a241cdf4-5e83-47b1-ad2f-e1999bd26600/download
https://repositorio.unbosque.edu.co/bitstreams/0f8bb21c-3805-4860-9bb5-e35230e2074b/download
https://repositorio.unbosque.edu.co/bitstreams/f84163eb-1a24-458d-acb8-e425a0d62466/download
https://repositorio.unbosque.edu.co/bitstreams/103b6d3e-78df-4632-bbdb-4823d64b2ada/download
https://repositorio.unbosque.edu.co/bitstreams/faca2af6-f3df-4d3e-9ec8-3eae7037f962/download
bitstream.checksum.fl_str_mv 2d4dbde23a1b09abc868db9e6319b1d0
17cc15b951e7cc6b3728a574117320f9
50d1fad5d04646c0db64ba23911f52ca
cd98236ce1b2437c9789dccf356155b2
3b6ce8e9e36c89875e8cf39962fe8920
96fb12b18d34d4d228dda83669147eca
781886de6d18912222dccf6df3e0a2d9
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1834107964253798400
spelling Velandia Paris, María AngélicaReina López, Laura CamilaRodríguez Tavera, Ricardo Andrés2025-05-16T16:33:48Z2025-05-16T16:33:48Z2024-10https://hdl.handle.net/20.500.12495/14370Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coEl uso de métodos anticonceptivos ha presentado problemas de adherencia y aceptabilidad en Colombia y el mundo. Distintos estudios de la OMS indican que las mujeres aún cuando desean evitar el embarazo dejan de usar estos métodos debido a los efectos secundarios que presentan. La industria fármacéutica ha explorado diversos métodos anticonceptivos, en donde se han incluido los parches transdérmicos de microagujas como una alternativa con menos efectos secundarios y mayor adherencia al tratamiento. Se realizó una revisión bibliográfica utilizando la metodología PRISMA, donde se emplearon criterios de inclusión y exclusión, allí se analizaron 50 artículos con el fin de dar cumplimiento a los objetivos planteados. Se determinó que los parches transdérmicos de microagujas ofrecen ventajas significativas como una liberación controlada de fármacos. Los diferentes tipos de microagujas (sólidas, recubiertas, biodegradables, huecas y de hidrogel), demostraron diferencias en eficacia y caracteristicas de liberación. Las microagujas biodegradables permiten una liberación controlada de Levonorgestrel de hasta 45 días sin dejar ningún residuo biopeligroso, lo que convierte a los parches transdérmicos de microagujas en una opción innovadora y viable para la administración de Levonorgestrel debido a que facilita la entrega, siendo más eficiente y controlada, permitiendo mayor adherencia y aceptabilidad por los pacientes.PregradoQuímico FarmacéuticoThe use of contraceptive methods has presented problems of adherence and acceptability in Colombia and the world. Different WHO studies indicate that even when women want to avoid pregnancy, they stop using these methods due to the side effects they present. The pharmaceutical industry has explored various contraceptive methods, where transdermal microneedle patches have been included as an alternative with fewer side effects and greater adherence to treatment. A bibliographic review was carried out using the PRISMA methodology, where inclusion and exclusion criteria were used, and 50 articles were analyzed in order to fulfill the objectives. It was determined that transdermal microneedle patches offer significant advantages such as controlled drug release. The different types of microneedles (solid, coated, biodegradable, hollow and hydrogel) showed differences in efficacy and release characteristics. Biodegradable microneedles allow a controlled release of Levonorgestrel for up to 45 days without leaving any biohazardous residue, which makes transdermal microneedle patches an innovative and viable option for Levonorgestrel administration because it facilitates delivery, being more efficient and controlled, allowing greater adherence and acceptability by patients.application/pdfAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Acceso abiertohttps://purl.org/coar/access_right/c_abf2http://purl.org/coar/access_right/c_abf2Parches transdérmicos de microagujasLiberación controladaMicroagujas biodegradablesLevonorgestrelAceptabilidadAdherencia615.19Transdermal microneedle patchesControlled releaseBiodegradable microneedlesLevonorgestrelAcceptabilityAdherenceRevisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivosLiterature review: Transdermal microneedle patches transdermal microneedle patches for contraceptive drug deliveryQuímica FarmacéuticaUniversidad El BosqueFacultad de CienciasTesis/Trabajo de grado - Monografía - Pregradohttps://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/resource_type/c_7a1finfo:eu-repo/semantics/bachelorThesishttps://purl.org/coar/version/c_ab4af688f83e57aa1. Bitzer, J. La Realidad de Los Métodos Anticonceptivos. SciELO 2018, 23.2. Organización Mundial de la Salud Un Nuevo Estudio de La OMS Relaciona Las Altas Tasas de Embarazos No Planificados Con Las Deficiencias de Los Servicios de Planificación Familiar Available online: https://www.who.int/es/news/item/25-10-2019-high-rates-of-unintended-pregnancies-linked-to-gaps-in-family-planning-services-new-who-study.3. Gordon, L.P. El Método Ogino (o de Abstinencia Periódica Basada En El Ciclo Menstrual) Available online: https://kidshealth.org/es/teens/contraception-rhythm.html#:~:text=El%20m%C3%A9todo%20Ogino%20es%20una,ciclo%20mensual%20de%20una%20mujer.4. Cuervo-Vergara, S.A.; Garrido-Gutiérrez, J.D.; Vélez-Álvarez, G.A.; Zuleta-Tobón, J.J. Asociación Entre Conocimientos de Anticoncepción y Embarazo No Planeado. Estudio de Corte Transversal. Rev Colomb Obstet Ginecol 2015, 66, 160, doi:10.18597/rcog.21.5. Organización Mundial de la Salud Organización Mundial de La Salud Departamento de Salud Reproductiva e Investigaciones Conexas.6. MinSalud; Profamilia Encuesta Nacional de Demografía y Salud; 2015;7. MinSalud; Profamilia Conocimiento y Uso de Los Métodos Anticonceptivos Entre Los Colombianos Available online: https://www.minsalud.gov.co/Documents/General/20161212_B_ENDS%202015_Metodos_anticonceptivos.pdf.8. Park, P. Park’s Textbook of Preventive and Social Medicine; 24th ed.; Banarsidas Bhanot Publishers, 2017;9. National Institutes of Health ¿Cuáles Son Los Diferentes Tipos de Anticonceptivos? Available online: https://espanol.nichd.nih.gov/salud/temas/contraception/informacion/tipos.10. AEMPS Parches Transdérmicos11. Goldsmith, A.; Edelman, D.A. Tecnología Anticonceptiva: Presente y Futuro. Rev Colomb Obstet Ginecol 2021, 30, 93–101, doi:10.18597/rcog.2253.12. Chen, X.; Z.Y.-P.X.J.S.X.-L.L.Y.G.L.W.Z.-H. [Preparation of Triptolide-Loaded Dissolving Microneedles and Its Transdermal Penetration]. Pubmed 2021, 46, 5278–5283, doi:10.19540/j.cnki.cjcmm.20210330.303.13. McCrudden, M.T.C.; McAlister, E.; Courtenay, A.J.; González‐Vázquez, P.; Raj Singh, T.R.; Donnelly, R.F. Microneedle Applications in Improving Skin Appearance. Exp Dermatol 2015, 24, 561–566, doi:10.1111/exd.12723.14. Gómez Sánchez, P.I. ANTICONCEPCIÓN: PASADO, PRESENTE Y FUTURO; 1st ed.; Editorial Universidad Nacional de Colombia, 2010;15. Bitzer, J.; Gemzell-Danielsson, K.; Roumen, F.; Marintcheva-Petrova, M.; van Bakel, B.; Oddens, B.J. The CHOICE Study: Effect of Counselling on the Selection of Combined Hormonal Contraceptive Methods in 11 Countries. The European Journal of Contraception & Reproductive Health Care 2012, 17, 65–78, doi:10.3109/13625187.2011.637586.16. Karve, T.; Dandekar, A.; Agrahari, V.; Melissa Peet, M.; Banga, A.K.; Doncel, G.F. Long-Acting Transdermal Drug Delivery Formulations: Current Developments and Innovative Pharmaceutical Approaches. Adv Drug Deliv Rev 2024, 210, doi:10.1016/j.addr.2024.115326.17. Gupta, D.R.; Prabhakar, B.; Wairkar, S. Non-Oral Routes, Novel Formulations and Devices of Contraceptives: An Update. Journal of Controlled Release 2022, 345, 798–810, doi:10.1016/j.jconrel.2022.03.057.18. Rojas Mena, A.A. AVANCES EN TECNOLOGÍA: PARCHES DE MICROAGUJAS. Trabajo Fin de Grado, UNIVERSIDAD COMPLUTENSE, 2017.19. María Pilar Nakhle Eid Avances En Los Sistemas Transdermicos Para La Administracion de Farmacos (4), Universidad de la Laguna, 2022.20. Baryakova, T.H.; Pogostin, B.H.; Langer, R.; McHugh, K.J. Overcoming Barriers to Patient Adherence: The Case for Developing Innovative Drug Delivery Systems. Nat Rev Drug Discov 2023, 22, 387–409, doi:10.1038/s41573-023-00670-0.21. Lee, D.H.; Lim, S.; Kwak, S.S.; Kim, J. Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications. Adv Healthc Mater 2024, 13, doi:10.1002/adhm.202302375.22. Berdai Jiménez, S. El Administración Transdérmica de Fármacos En Microagujas. Trabajo fin de Grado, UNIVERSIDAD COMPLUTENSE, 2020.23. Le, Z.; Yu, J.; Quek, Y.J.; Bai, B.; Li, X.; Shou, Y.; Myint, B.; Xu, C.; Tay, A. Design Principles of Microneedles for Drug Delivery and Sampling Applications. Materials Today 2023, 63, 137–169, doi:10.1016/j.mattod.2022.10.025.24. Jung, J.H.; Jin, S.G. Microneedle for Transdermal Drug Delivery: Current Trends and Fabrication. J Pharm Investig 2021, 51, 503–517, doi:10.1007/s40005-021-00512-4.25. Wong, W.F.; Ang, K.P.; Sethi, G.; Looi, C.Y. Recent Advancement of Medical Patch for Transdermal Drug Delivery. Medicina (Lithuania) 2023, 59, doi:10.3390/medicina59040778.26. Yao, G.; Quan, G.; Lin, S.; Peng, T.; Wang, Q.; Ran, H.; Chen, H.; Zhang, Q.; Wang, L.; Pan, X.; et al. Novel Dissolving Microneedles for Enhanced Transdermal Delivery of Levonorgestrel: In Vitro and in Vivo Characterization. Int J Pharm 2017, 534, 378–386, doi:10.1016/j.ijpharm.2017.10.035.27. Altuntaş, E.; Tekko, I.A.; Vora, L.K.; Kumar, N.; Brodsky, R.; Chevallier, O.; McAlister, E.; Kurnia Anjani, Q.; McCarthy, H.O.; Donnelly, R.F. Nestorone Nanosuspension-Loaded Dissolving Microneedles Array Patch: A Promising Novel Approach for “on-Demand” Hormonal Female-Controlled Peritcoital Contraception. Int J Pharm 2022, 614, doi:10.1016/j.ijpharm.2021.121422.28. Jiang, X.; Zeng, Y.; Zhang, W.; Wang, C.; Li, W. Advances in Microneedle Patches for Long-Acting Contraception. Acta Materia Medica 2023, 2, doi:10.15212/AMM-2022-0042.29. Li, W.; Terry, R.N.; Tang, J.; Feng, M.R.; Schwendeman, S.P.; Prausnitz, M.R. Rapidly Separable Microneedle Patch for the Sustained Release of a Contraceptive. Nat Biomed Eng 2019, 3, 220–229, doi:10.1038/s41551-018-0337-4.30. Abdelkader, H.; Fathalla, Z.; Seyfoddin, A.; Farahani, M.; Thrimawithana, T.; Allahham, A.; Alani, A.W.G.; Al-Kinani, A.A.; Alany, R.G. Polymeric Long-Acting Drug Delivery Systems (LADDS) for Treatment of Chronic Diseases: Inserts, Patches, Wafers, and Implants. Adv Drug Deliv Rev 2021, 177, doi:10.1016/j.addr.2021.113957.31. Zhang, W.; Zhang, W.; Li, C.; Zhang, J.; Qin, L.; Lai, Y. Recent Advances of Microneedles and Their Application in Disease Treatment. Int J Mol Sci 2022, 23, doi:10.3390/ijms23052401.32. Yadav, P.R.; Munni, M.N.; Campbell, L.; Mostofa, G.; Dobson, L.; Shittu, M.; Pattanayek, S.K.; Uddin, M.J.; Bhusan Das, D. Translation of Polymeric Microneedles for Treatment of Human Diseases: Recent Trends, Progress, and Challenges. Pharmaceutics 2021, 13, doi:10.3390/pharmaceutics13081132.33. Avcil, M.; Çelik, A. Microneedles in Drug Delivery: Progress and Challenges. Micromachines (Basel) 2021, 12, doi:10.3390/mi12111321.34. Priya, B.; Manoj, K.; Navneet, K. A Review of Recent Advancement of Transdermal Drug Delivery Systems. International Journal of Research Development and Technology 2023, 1.35. Sheth, N.S.; Mistry, R.B. Formulation and Evaluation of Transdermal Patches and to Study Permeation Enhancement Effect of Eugenol. J Appl Pharm Sci 2011, 01, 96–101.36. Kim, S.; Kim, J.H.; Jeon, O.; Kwon, I.C.; Park, K. Engineered Polymers for Advanced Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics 2009, 71, 420–430, doi:10.1016/j.ejpb.2008.09.021.37. Vora, L.K.; Sabri, A.H.; Naser, Y.; Himawan, A.; Hutton, A.R.J.; Anjani, Q.K.; Volpe-Zanutto, F.; Mishra, D.; Li, M.; Rodgers, A.M.; et al. Long-Acting Microneedle Formulations. Adv Drug Deliv Rev 2023, 201, doi:10.1016/j.addr.2023.115055.38. Parhi, R. Recent Advances in Microneedle Designs and Their Applications in Drug and Cosmeceutical Delivery. J Drug Deliv Sci Technol 2022, 75, doi:10.1016/j.jddst.2022.103639.39. Filho, D.; Guerrero, M.; Pariguana, M.; Marican, A.; Durán-Lara, E.F. Hydrogel-Based Microneedle as a Drug Delivery System. Pharmaceutics 2023, 15, doi:10.3390/pharmaceutics15102444.40. Hou, X.; Li, J.; Hong, Y.; Ruan, H.; Long, M.; Feng, N.; Zhang, Y. Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery. Biomedicines 2023, 11, doi:10.3390/biomedicines11082119.41. Luo, X.; Yang, L.; Cui, Y. Microneedles: Materials, Fabrication, and Biomedical Applications. Biomed Microdevices 2023, 25, doi:10.1007/s10544-023-00658-y.42. Parhi, R.; Divya Supriya, N. Review of Microneedle Based Transdermal Drug Delivery Systems. International Journal of Pharmaceutical Sciences and Nanotechnology 2019, 12, doi:10.37285/ijpsn.2019.12.3.1.43. Halder, J.; Gupta, S.; Kumari, R.; Gupta, G. Das; Rai, V.K. Microneedle Array: Applications, Recent Advances, and Clinical Pertinence in Transdermal Drug Delivery. J Pharm Innov 2021, 16, 558–565, doi:10.1007/s12247-020-09460-2.44. Rathor, S.; Ram, A.; Ghasidas Vishwavidyalaya, G. ADVANCEMENT IN TRANSDERMAL DRUG DELIVERY SYSTEM : MICRONEEDLES. Asian Journal of Pharmaceutical Research and Development 2017, 5, 1–07.45. Oliveira, C.; Teixeira, J.A.; Oliveira, N.; Ferreira, S.; Botelho, C.M. Microneedles’ Device: Design, Fabrication, and Applications. Macromol 2024, 4, 320–355, doi:10.3390/macromol4020019.46. Vora, L.K.; Moffatt, K.; Tekko, I.A.; Paredes, A.J.; Volpe-Zanutto, F.; Mishra, D.; Peng, K.; Raj Singh Thakur, R.; Donnelly, R.F. Microneedle Array Systems for Long-Acting Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics 2021, 159, 44–76, doi:10.1016/j.ejpb.2020.12.006.47. Singh, P.; Carrier, A.; Chen, Y.; Lin, S.; Wang, J.; Cui, S.; Zhang, X. Polymeric Microneedles for Controlled Transdermal Drug Delivery. Journal of Controlled Release 2019, 315, 97–113, doi:10.1016/j.jconrel.2019.10.022.48. Wang, S.; Zhao, M.; Yan, Y.; Li, P.; Huang, W. Flexible Monitoring, Diagnosis, and Therapy by Microneedles with Versatile Materials and Devices toward Multifunction Scope. Research 2023, 6, 01–28, doi:10.34133/research.0128.49. Loh, J.M.; Lim, Y.J.L.; Tay, J.T.; Cheng, H.M.; Tey, H.L.; Liang, K. Design and Fabrication of Customizable Microneedles Enabled by 3D Printing for Biomedical Applications. Bioact Mater 2024, 32, 222–241, doi:10.1016/j.bioactmat.2023.09.022.50. Serrano Castañeda, P. Desarrollo de Una Nueva Forma Farmacéutica a Base de Microagujas Poliméricas Biodegradables Acopladas a Un Parche Transdérmico Para La Liberación de Fármacos. Tesis, UNIVERSIDAD AUTÓNOMA METROPOLITANA, 2019.51. Magill, E.; Demartis, S.; Gavini, E.; Permana, A.D.; Thakur, R.R.S.; Adrianto, M.F.; Waite, D.; Glover, K.; Picco, C.J.; Korelidou, A.; et al. Solid Implantable Devices for Sustained Drug Delivery. Adv Drug Deliv Rev 2023, 199, doi:10.1016/j.addr.2023.114950.52. Conrad, R. ¿Qué Es Moldeo Por Inyección? Available online: https://www.elastomer.kuraray.com/es/blog/injection-molding/ (accessed on 21 September 2024).53. Xu, J.; Xu, D.; Xuan, X.; He, H. Advances of Microneedles in Biomedical Applications. Molecules 2021, 26, doi:10.3390/molecules26195912.54. Ramadon, D.; McCrudden, M.T.C.; Courtenay, A.J.; Donnelly, R.F. Enhancement Strategies for Transdermal Drug Delivery Systems: Current Trends and Applications. Drug Deliv Transl Res 2022, 12, 758–791, doi:10.1007/s13346-021-00909-6.55. Sabri, A.H.; Kim, Y.; Marlow, M.; Scurr, D.J.; Segal, J.; Banga, A.K.; Kagan, L.; Lee, J.B. Intradermal and Transdermal Drug Delivery Using Microneedles – Fabrication, Performance Evaluation and Application to Lymphatic Delivery. Adv Drug Deliv Rev 2020, 153, 195–215, doi:10.1016/j.addr.2019.10.004.56. Morales Florido, M.I.; Miranda Calderón, J.E.; Gómez Sámano, M.A.; Escobar Chávez, J.J. Microneedles as an Alternative Strategy for Drug Delivery. J Pharm Pharm Sci 2022, 25, 93–109.57. Ebrahiminejad, V.; Rad, Z.F.; Prewett, P.D.; Davies, G.J. Fabrication and Testing of Polymer Microneedles for Transdermal Drug Delivery. Beilstein Journal of Nanotechnologyp0o 2022, 13, 629–640, doi:10.3762/bjnano.13.55.58. Li, W.; Tang, J.; Terry, R.N.; Li, S.; Brunie, A.; Callahan, R.L.; Noel, R.K.; Rodríguez, C.A.; Schwendeman, S.P.; Prausnitz, M.R. Long-Acting Reversible Contraception by Effervescent Microneedle Patch. Sci Adv 2019, 5.59. Li, W.; Chen, J.Y.; Terry, R.N.; Tang, J.; Romanyuk, A.; Schwendeman, S.P.; Prausnitz, M.R. Core-Shell Microneedle Patch for Six-Month Controlled-Release Contraceptive Delivery. Journal of Controlled Release 2022, 347, 489–499, doi:10.1016/j.jconrel.2022.04.051.60. Paredes, A.J.; Ramöller, I.K.; McKenna, P.E.; Abbate, M.T.A.; Volpe-Zanutto, F.; Vora, L.K.; Kilbourne-Brook, M.; Jarrahian, C.; Moffatt, K.; Zhang, C.; et al. Microarray Patches: Breaking down the Barriers to Contraceptive Care and HIV Prevention for Women across the Globe. Adv Drug Deliv Rev 2021, 173, 331–348, doi:10.1016/j.addr.2021.04.002.61. Xu, C.; Wu, Y.; Zhao, L.; Zhou, W.; Li, Y.; Yi, X.; Wang, Y.; Zhang, Q.; Hu, H.; Wang, Z. Transdermal Hormone Delivery: Strategies, Application and Modality Selection. J Drug Deliv Sci Technol 2023, 86, doi:10.1016/j.jddst.2023.104730.62. Yavuz, B.; Chambre, L.; Harrington, K.; Kluge, J.; Valenti, L.; Kaplan, D.L. Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel. ACS Appl Bio Mater 2020, 3, 5375–5382, doi:10.1021/acsabm.0c00671.63. Sivasankaran, S.; Jonnalagadda, S. Advances in Controlled Release Hormonal Technologies for Contraception: A Review of Existing Devices, Underlying Mechanisms, and Future Directions. Journal of Controlled Release 2021, 330, 797–811, doi:10.1016/j.jconrel.2020.12.044.64. VADEMECUM ORTHO EVRA Transdermal Patch 150 Μg/24 H+20 Μg/24 h Available online: https://www.vademecum.es/estados-unidos/medicamento/28003194/ortho-evra-transdermal-patch-150-g-24-h-20-g-24-h (accessed on 18 September 2024).65. Li, W.; Li, S.; Fan, X.; Prausnitz, M.R. Microneedle Patch Designs to Increase Dose Administered to Human Subjects. Journal of Controlled Release 2021, 339, 350–360, doi:10.1016/j.jconrel.2021.09.036.spaORIGINALTrabajo de grado.pdfTrabajo de grado.pdfapplication/pdf1133528https://repositorio.unbosque.edu.co/bitstreams/5994f216-e4bc-428f-bea3-f47c42129827/download2d4dbde23a1b09abc868db9e6319b1d0MD57LICENSElicense.txtlicense.txttext/plain; charset=utf-82000https://repositorio.unbosque.edu.co/bitstreams/3488d174-4a7d-428e-94c3-fe89932ca878/download17cc15b951e7cc6b3728a574117320f9MD54Carta de autorizacion.pdfapplication/pdf746784https://repositorio.unbosque.edu.co/bitstreams/a241cdf4-5e83-47b1-ad2f-e1999bd26600/download50d1fad5d04646c0db64ba23911f52caMD59Anexo 1 Acta de aprobacion.pdfapplication/pdf1612061https://repositorio.unbosque.edu.co/bitstreams/0f8bb21c-3805-4860-9bb5-e35230e2074b/downloadcd98236ce1b2437c9789dccf356155b2MD510CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8899https://repositorio.unbosque.edu.co/bitstreams/f84163eb-1a24-458d-acb8-e425a0d62466/download3b6ce8e9e36c89875e8cf39962fe8920MD58TEXTTrabajo de grado.pdf.txtTrabajo de grado.pdf.txtExtracted texttext/plain83894https://repositorio.unbosque.edu.co/bitstreams/103b6d3e-78df-4632-bbdb-4823d64b2ada/download96fb12b18d34d4d228dda83669147ecaMD511THUMBNAILTrabajo de grado.pdf.jpgTrabajo de grado.pdf.jpgGenerated Thumbnailimage/jpeg5350https://repositorio.unbosque.edu.co/bitstreams/faca2af6-f3df-4d3e-9ec8-3eae7037f962/download781886de6d18912222dccf6df3e0a2d9MD51220.500.12495/14370oai:repositorio.unbosque.edu.co:20.500.12495/143702025-05-17 05:06:11.578http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internationalopen.accesshttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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